Efficacy of treatment intensification with adalimumab, etanercept and infliximab in rheumatoid arthritis: a systematic review of cohort studies with focus on dose

Grith Eng; Michael B Stoltenberg; Marcin Szkudlarek; Pierre N Bouchelouche; Robin Christensen; Henning Bliddal; Else Marie Bartels

doi:10.1016/j.semarthrit.2013.01.007

Efficacy of treatment intensification with adalimumab, etanercept and infliximab in rheumatoid arthritis: a systematic review of cohort studies with focus on dose

Grith Eng, Michael B Stoltenberg, Marcin Szkudlarek, Pierre N Bouchelouche, Robin Christensen, Henning Bliddal, Else Marie Bartels

Parker Instituttet

16 Citationer (Scopus)

Abstract

To summarize the empirical evidence regarding the effect of treatment intensification on clinical outcomes in patients with rheumatoid arthritis treated with one of the TNF-α-inhibitors, adalimumab, etanercept or infliximab.

Originalsprog	Engelsk
Tidsskrift	Seminars in Arthritis and Rheumatism
Vol/bind	43
Udgave nummer	2
Sider (fra-til)	144-51
Antal sider	8
ISSN	0049-0172
DOI	https://doi.org/10.1016/j.semarthrit.2013.01.007
Status	Udgivet - okt. 2013

Adgang til dokumentet

10.1016/j.semarthrit.2013.01.007

Citationsformater

Eng, G., Stoltenberg, M. B., Szkudlarek, M., Bouchelouche, P. N., Christensen, R., Bliddal, H., & Marie Bartels, E. (2013). Efficacy of treatment intensification with adalimumab, etanercept and infliximab in rheumatoid arthritis: a systematic review of cohort studies with focus on dose. Seminars in Arthritis and Rheumatism, 43(2), 144-51. https://doi.org/10.1016/j.semarthrit.2013.01.007

Efficacy of treatment intensification with adalimumab, etanercept and infliximab in rheumatoid arthritis: a systematic review of cohort studies with focus on dose. / Eng, Grith; Stoltenberg, Michael B; Szkudlarek, Marcin et al.
I: Seminars in Arthritis and Rheumatism, Bind 43, Nr. 2, 10.2013, s. 144-51.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

Eng, G, Stoltenberg, MB, Szkudlarek, M, Bouchelouche, PN, Christensen, R , Bliddal, H & Marie Bartels, E 2013, 'Efficacy of treatment intensification with adalimumab, etanercept and infliximab in rheumatoid arthritis: a systematic review of cohort studies with focus on dose', Seminars in Arthritis and Rheumatism, bind 43, nr. 2, s. 144-51. https://doi.org/10.1016/j.semarthrit.2013.01.007

@article{7ea302b00e5b4863bd574a686d084706,

title = "Efficacy of treatment intensification with adalimumab, etanercept and infliximab in rheumatoid arthritis: a systematic review of cohort studies with focus on dose",

abstract = "To summarize the empirical evidence regarding the effect of treatment intensification on clinical outcomes in patients with rheumatoid arthritis treated with one of the TNF-α-inhibitors, adalimumab, etanercept or infliximab.",

author = "Grith Eng and Stoltenberg, {Michael B} and Marcin Szkudlarek and Bouchelouche, {Pierre N} and Robin Christensen and Henning Bliddal and {Marie Bartels}, Else",

year = "2013",

month = oct,

doi = "10.1016/j.semarthrit.2013.01.007",

language = "English",

volume = "43",

pages = "144--51",

journal = "Seminars in Arthritis and Rheumatism",

issn = "0049-0172",

publisher = "W.B./Saunders Co",

number = "2",

}

TY - JOUR

T1 - Efficacy of treatment intensification with adalimumab, etanercept and infliximab in rheumatoid arthritis

T2 - a systematic review of cohort studies with focus on dose

AU - Eng, Grith

AU - Stoltenberg, Michael B

AU - Szkudlarek, Marcin

AU - Bouchelouche, Pierre N

AU - Christensen, Robin

AU - Bliddal, Henning

AU - Marie Bartels, Else

PY - 2013/10

Y1 - 2013/10

N2 - To summarize the empirical evidence regarding the effect of treatment intensification on clinical outcomes in patients with rheumatoid arthritis treated with one of the TNF-α-inhibitors, adalimumab, etanercept or infliximab.

AB - To summarize the empirical evidence regarding the effect of treatment intensification on clinical outcomes in patients with rheumatoid arthritis treated with one of the TNF-α-inhibitors, adalimumab, etanercept or infliximab.

U2 - 10.1016/j.semarthrit.2013.01.007

DO - 10.1016/j.semarthrit.2013.01.007

M3 - Journal article

C2 - 23838092

SN - 0049-0172

VL - 43

SP - 144

EP - 151

JO - Seminars in Arthritis and Rheumatism

JF - Seminars in Arthritis and Rheumatism

IS - 2

ER -

Efficacy of treatment intensification with adalimumab, etanercept and infliximab in rheumatoid arthritis: a systematic review of cohort studies with focus on dose

Abstract

Adgang til dokumentet

Fingeraftryk

Citationsformater